Phase 2 COPD
Research Grant
Administered By
Duke Clinical Research Institute
Awarded By
Pfizer, Inc.
Start Date
November 14, 2024
End Date
December 1, 2024
Administered By
Duke Clinical Research Institute
Awarded By
Pfizer, Inc.
Start Date
November 14, 2024
End Date
December 1, 2024